Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide- induced apoptosis in hippocampus-derived adult neural stem cells

Journal of Pharmacological Sciences

Volumn 104, Issue 1, 2007, Pages 61-72

  Huang, Yu Yin ^a,b   Peng, Chi Hsien ^a,d   Yang, Yi Ping ^a   Wu, Chih Chiau ^a   Hsu, Wen Ming ^a   Wang, Hsiao Jung ^a   Chan, Kwok Han ^a   Chou, Yi Pen ^b   Chen, Shih Jen ^a   Chang, Yuh Lih ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Desipramine; Neural stem cell; Real time RT PCR; Small interfering rna (siRNA)

Indexed keywords

DESIPRAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NESTIN; NORADRENALIN; PROTEIN BCL 2; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IN VITRO STUDY; NEURAL STEM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 34249107980     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0061255     Document Type: Article

References (46)

1. Friedman RA, Kocsis JH. Pharmacotherapy for chronic depression. Psychiatr Clin North Am. 1996;19:121-132.
2. Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, et al. Fluoxetine versus other types of pharmaco-therapy for depression. Cochrane Database Syst Rev. 2005;4:CD004185.
3. Martinez TR, Frechilla D, Del RJ. Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology. 2002;43:1230-1237.
4. Carignani C, Corsi M. Inhibition of SK3 channels in the TE671 human medulloblastoma cell line by desipramine and imipramine. Eur J Pharmacol. 2002;448:139-142.
5. Pariante CM, Makoff A, Lovestone S, Feroli S, Heyden A, Miller AH, et al. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol. 2001;134:1335-1343.
6. Shin JG, Park JY, Kim MJ, Shon JH, Yoon YR, Cha IJ, et al. Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: Mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos. 2002;30:1102-1107.
7. Morishita S, Watanabe S. Effect of the tricyclic antidepressant desipramine on protein kinase C in rat brain and rabbit platelets in vitro. Psychiatry Clin Neurosci. 1997;51:249-252.
8. Sapolsky RM. Why stress is bad for your brain. Science. 1996;273:749-750.
9. Gurvits TV, Shenton ME, Hokama H, Ohta H, Lasko NB, Gilbertson MW, et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry. 1996;40:1091-1099.
10. Lee HJ, Kim JW, Yim SV, Kim MJ, Kim SA, Kim YJ, et al. Fluoxetine enhances cell proliferation and prevents apoptosis in dentate gyrus of maternally separated rats. Mol Psychiatry. 2001;610:725-728.
11. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science. 2003;301:805-809.
12. Chen H, Pandey GN, Dwivedi Y. Hippocampal cell proliferation regulation by repeated stress and antidepressants. Neuroreport. 2006;17:863-867.
13. Gage FH. Mammalian neural stem cells. Science. 2000;287:1433-1438.
14. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol. 2005;23:862-871.
15. Yasuki I. Control of proliferation and differentiation of neural precursor cells: focusing on the developing cerebellum. J Pharmacol Sci. 2006;101:183-188.
16. Liu IH, Chen SJ, Ku HH, Kao CL, Tsai FT, Hsu WM, et al. Comparison of the proliferation and differentiation ability between adult rat retinal stem cells and cerebral cortex-derived neural stem cells. Ophthalmologica. 2005;219:171-176.
17. Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol. 2001;16:95-103.
18. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry. 2003;54:566-572.
19. O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol. 2004;19:397-403.
20. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445-452.
21. Manji HK, Moore GJ, Rajkowska G, Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry. 2000;5:578-593.
22. Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers target cellular plasticity and resilience cascades: mplications for the development of novel therapeutics. Mol Neurobiol. 2005;32:173-202.
23. Kao CL, Chiou SH, Chen YJ, Singh S, Lin HT, Liu RS, et al. Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system. Mod Pathol. 2005;18:769-778.
24. Chiou SH, Liu JH, Hsu WM, Chen SS, Chang SY, Juan LJ, et al. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J Immunol. 2001;167:4098-4103.
25. Cheng FC, Kuo JS, Huang HM, Yang DY, Wu TF, Tsai TH. Determination of catecholamines in pheochromocytoma cell (PC-12) culture medium by microdialysis-microbore liquid chromatography. J Chromatogr A. 2000;870:405-411.
26. Franchi L, Condo I, Tomassini B, Nicolo C, Testi R. A caspase-like activity is triggered by LPS and is required for survival of human dendritic cells. Blood. 2003;102:2910-2915.
27. Yu LC, Flynn AN, Turner JR, Buret AG. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J. 2005;19:1822-1835.
28. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000;886:172-189.
29. Wright SC, Zhong J, Larrick JW. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 1994;8:654-660.
30. Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry. 2004;56:570-580.
31. Myers KM, Fiskum G., Liu Y, Simmens SJ, Bredesen DE, Murphy AN. Bcl-2 protects neural cells from cyanide/aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability. J Neurochem. 1995;65:2432-2440.
32. Mizuguchi M, Ikeda K, Asada M, Mizutani S, Kamoshita S. Expression of Bcl-2 protein in murine neural cells in culture. Brain Res. 1994;649:197-202.
33. Ozdener H. Inducible functional expression of Bcl-2 in human astrocytes derived from NTera-2 cells. J Neurosci Methods. 2007;159:8-18.
34. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005;162:175-177.
35. Hellstrom IC, Danik M, Luheshi GN, Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus. 2005;15:656-664.
36. Kubera M, Lin AH, Kenis G., Bosmans E, van Bockstaele D, Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma/ interleukin-10 production ratio. J Clin Psychopharmacol. 2001;21:199-206.
37. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci. 2003;23:7311-7316.
38. Mercier G, Lennon AM, Renouf B, Dessouroux A, Ramauge M, Courtin F, et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci. 2004;24:207-216.
39. Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience. 2005;135:659-678.
40. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry. 2007;61:661-670.
41. Choi IJ, Kim JS, Kim JM, Jung HC, Song IS. Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun. 2003;71:830-837.
42. Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci. 1996;19:463-489.
43. Jiao J, Huang X, Feit-Leithman RA, Neve RL, Snider W, Dartt DA, et al. Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. EMBO J. 2005;24:1068-1078.
44. Lesch KP. Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord. 2001;62:57-76.
45. Ou XM, Chen K, Shih JC. Monoamine oxidase A and repressor R1 are involved in apoptotic signaling pathway. Proc Natl Acad Sci U S A. 2006;103:10923-10928.
46. Egan CG. Differentiation of hippocampal stem cells into functional neurons: evolving our understanding of monoamine oxidase-A inhibition. Br J Pharmacol. 2006;148:563-564.